Cockroach Labs logo

Cockroach Labs Stock Price, Valuation & IPO

Last updated on 16 December 2021
Private companyWatchlist

Cockroach Labs is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Last known price (Dec 2021)
$20.40/ share
As of 16 December 2021
Last Round Valuation$5BSeries F, December 2021
Total Funding$633M
Analytics

Track Cockroach Labs Stock Price

We monitor the Cockroach Labs stock price based on the latest private market data and funding rounds. Since there is no Cockroach Labs stock symbol on public exchanges yet, we provide a consensus price to help you track your investment.

No recorded secondary trades since December 2021Get notified
About company

Cockroach Labs

Cockroach Labs is an American developer of the distributed database CockroachDB, founded in 2015 in New York. The database is designed for systems that cannot stop and holds data simultaneously in multiple regions. It powers ChatGPT accounts, serving more than 800 million users per week, DoorDash orders, and Netflix services. DoorDash alone has 1.9 PB of data, more than 300 clusters, and 1.2 million queries per second in the database, and launching in a new country does not require a separate team of administrators. The largest US bookmaker FanDuel maintains a unified financial ledger on CockroachDB with a wallet for 13 million accounts, distributed across 28 states according to regulatory requirements. Series F led by Greenoaks took place at a valuation of $5 billion, with a total of $633 million raised.

Founded2015
HeadquartersNew York, USA
IndustryEnterprise Software
Efficiency

Key Metrics Dynamic

See the performance of Cockroach Labs's key metrics, based on real market data.

2021—
Share Price (EoY)$20.40
Company financing

Funding rounds

F2021-12-16
Valuation$5B
Price
E2021-01-12
Valuation$2B
Price
D2020-05-05
Valuation$715M
Price
C2019-08-06
Valuation$535M
Price
B2017-05-10
Valuation$289M
Price
A-12016-03-30
Valuation$137M
Price
A2015-06-04
Valuation$25M
Price
Key Investors
Total raised$633M
Advantages

Key highlights

Where Cockroach Labs stands today across technology, financials and market traction.

1.0

OpenAI: ChatGPT accounts.

The ChatGPT account and authorization system was built on CockroachDB together with the open-source identity server ORY. It serves more than 800 million users per week and delivers data worldwide.

2.0

DoorDash: 1.2 million requests per second.

The delivery service switched to CockroachDB from Amazon Aurora for PostgreSQL. Now it has more than 300 clusters and 1.9 PB of data, and launching in a new country does not require a separate team of administrators.

3.0

FanDuel: common wallet in 28 states.

The largest US bookmaker moved away from a MySQL cluster for a unified financial ledger. The law requires bets to be processed in the state where they were placed, and the database maintains a ledger in each state with a total wallet of 13 million accounts.

FAQ

Frequently Asked Questions

Not on a public exchange — Cockroach Labs is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

A private company has no single official share price. AXEVIL's consensus estimate is $20.40 per share as of 16 December 2021. Its most recent round implied a post-money valuation of $5B (December 2021).

Cockroach Labs's most recent funding round valued the company at $5B post-money (December 2021) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

No. Cockroach Labs is a private company and its shares are not listed on any public exchange.

No. Cockroach Labs has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.

Email Newsletter

Get Updates

Stay informed about Cockroach Labs stock news and new investment rounds.

Risk disclosure and data sources

Secondary-market prices and investment round data on this page, current and historical, are based on publicly available information and on data from market participants, and are provided for informational purposes only. Axevil Capital strives for accuracy; all prices and valuations are approximate and may fluctuate significantly due to low liquidity and limited access to information. The secondary market for private company shares is illiquid and does not guarantee the ability to buy or sell shares at the displayed price.

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Axevil Capital, LLC is a Delaware limited liability company (registration No. 6832739) operating as an investment adviser relying on an exemption from registration, filed with the SEC as an Exempt Reporting Adviser (SEC file No. 802-126907; CRD No. 323970). ERA status means the Company files reports with the SEC but is not a registered investment adviser. The Company is not a broker-dealer and is not a member of FINRA or SIPC.

Full legal disclosures · Terms of use

San Francisco548 Market St, San Francisco, California, 94104, United States
DubaiThe One Tower, 23rd Floor, Office 13, Dubai, United Arab Emirates
AstanaOffice 338, 55/23 Mangilik El Avenue, Astana, Republic of Kazakhstan

Axevil Capital, LLC is a company (Delaware, #6832739) with legal address: 548 Market St, San Francisco, California, 94104, United States.

Axevil Capital, LLC has Exempt Reporting Adviser (ERA) status (SEC #802−126907).

The information presented on the website is for informational purposes only and:
— does not constitute an offer to buy or sell securities or other financial instruments;
— does not constitute an invitation to trade or provision of investment services;
— does not constitute individual investment advice.

The Company works exclusively with qualified investors who possess the necessary knowledge, experience, and financial capacity to assess risks and invest in high-risk instruments. This asset class involves elevated risks, volatility, and illiquidity. Investors must be prepared to accept the possibility of total loss of invested capital as well as lack of liquidity.

NOTIFICATION OF INVESTMENT RISKS AND STATUS OF THE COMPANY'S ACTIVITIES

FOR ALL INVESTORS GENERALLY:
The Company's activities focus on attracting investments in mature venture projects at the stage of sustainable business development, close to IPO exit.
The Company does not guarantee profit generation. Investments involve risks, including the possibility of returns below expectations, which cannot be guaranteed.

NOTICE TO INVESTORS IN THE UNITED STATES:
— Investment interest offerings are conducted as private placements and are not subject to registration under US securities laws.
— Available only to accredited investors.
— Such securities may have transfer and resale restrictions.
— Investments carry a high level of financial risk.
— Independent legal, tax, and financial consultation is strongly recommended before making investment decisions.

NOTICE TO RESIDENTS OF THE UNITED ARAB EMIRATES (UAE):
— Investment interest offerings are not public in the UAE.
— Directed only to qualified institutional investors.
— Interests are not registered or approved by the UAE Central Bank, SCA, or other regulators.

NOTICE TO RESIDENTS OF ITALY:
— Interest offerings are not authorized by Italian regulators under Decreto Legislativo No. 58/1998.
— Interests may not be offered, distributed, or sold to the general public.

NOTICE TO RESIDENTS OF THE UNITED KINGDOM:
— SPVs constitute unregulated collective investment schemes under FSMA 2000.
— Promotion is restricted and permitted only to "relevant persons" within the meaning of Financial Promotion Order 2005 (Articles 19(5), 49(2)(a)-(d)).
— Most standard protections of the UK regulatory system do not apply.
— Compensation under the UK Financial Services Compensation Scheme is not provided.

NOTICE TO RESIDENTS OF SWEDEN:
— The partnership is not an investment fund under the Swedish Investment Funds Act (2004:46).
— The offering is not subject to registration under the Swedish Financial Instruments Trading Act (1991:980).
— Interests are not approved and will not be approved by the Swedish Financial Supervisory Authority.

NOTICE TO RESIDENTS OF SWITZERLAND:
— SPVs are not approved by FINMA as foreign collective investment schemes under Article 120 CISA. Interests may not be publicly offered or distributed in Switzerland.
— SPVs are not regulated by Swiss authorities.
— Interests are available only to "qualified investors" under CISA or a limited circle of persons without public offering.
— By continuing, you confirm that:
1. You qualify as an accredited/qualified investor under the laws of your jurisdiction (e.g., in the U.S. an annual income exceeding $200,000 individually or $300,000 jointly, or net worth above $1 million, excluding primary residence).
2. You are legally permitted to access this information in your jurisdiction.
3. You understand that private investments involve a high degree of risk, including the risk of total loss of capital.

Axevil Capital 2021−2026 — All Rights Reserved